AGENDA

Boston, 4 - 6 November 2025

Schedule

Create your personal agenda –check the favourite icon

Nov 58:00
Conference pass

Registration & Expo Hall Opens

Breaks

Registration & Expo Hall Opens

Nov 58:30
Conference pass

Organizer's Opening Remarks

Keynotes
Kaylee Nguyen, Senior Conference Director, Terrapinn
Keynote Stage - Hall C
Nov 58:35
Conference pass
Nov 58:40
Conference pass

Keynote Sponsored by ArisGlobal

Keynotes
Keynote Stage - Hall C
Nov 59:00
Conference pass

Keynote Presentation: We Simplify Pharmacovigilance

Keynotes

Sponsored by EVERSANA.

Vivek Ahuja, Executive Vice President, EVERSANA
Keynote Stage - Hall C
Nov 59:20
Conference pass

Keynote: Adapting in Real Time: Future-Proofing Pharmacovigilance Through Innovation

Keynotes

In an increasingly dynamic global healthcare landscape, the need for agile, forward-thinking pharmacovigilance systems has never been more urgent. This panel will explore how real-time technologies, predictive analytics, AI/ML tools, and collaborative data ecosystems are revolutionizing the way safety signals are detected, assessed, and acted upon.

Badrish Patel, M.D., Vice President, Global Drug Safety and Pharmacovigilance, Jazz Pharmaceuticals
Keynote Stage - Hall C
Nov 510:20
Conference pass

Networking, Posters, & Expo Hall Break

Breaks

Networking, Posters, & Expo Hall Break

Hall C
Nov 510:55
Conference pass

Track Chairperson's Opening Remarks

AI & Automation

Attendees will gain a deep understanding of how AI, machine learning, and automation are revolutionizing pharmacovigilance by streamlining case processing, enhancing signal detection, and driving operational efficiency. They will explore real-world applications, innovative tools, and forward-looking strategies to build trust in AI and future-proof safety operations across the drug development lifecycle.

Nov 510:55
Conference pass

Track Chairperson's Opening Remarks

Global PV & Regulatory

Attendees will gain insights into evolving global pharmacovigilance regulations, harmonization efforts, and compliance strategies across diverse markets. Through expert perspectives and case studies, they will explore how to navigate complex regulatory frameworks, align with international guidance, and implement best practices to ensure safety and compliance on a global scale.

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI
Nov 510:55
Conference pass

Track Chairperson's Opening Remarks

Safety Risk Management

Attendees will gain practical strategies for identifying, assessing, and mitigating safety risks throughout the product lifecycle. They will explore evolving approaches to benefit-risk management, REMS, and post-market surveillance, with insights into regulatory expectations and innovative tools to enhance patient safety and product oversight.

Joan Daouza, Consultant, Consultant
Nov 510:55
Conference pass

Track Chairperson's Opening Remarks

Next Gen Tech & Data

Attendees will gain a forward-looking view of how emerging technologies and advanced data analytics are shaping the future of pharmacovigilance. They will explore innovations in real-world evidence, signal detection, and data integration to enhance decision-making, optimize safety monitoring, and support more proactive risk management.

Nov 510:55
Conference pass

Track Chairperson's Opening Remarks

Patient Safety & Centricity

To be announced.

Nov 510:55
Conference pass

Track Chairperson's Opening Remarks

Digital Transformation

To be announced.

Nov 510:55
Conference pass

Track Chairperson's Opening Remarks

Quality Assurance

To be announced.

Nov 511:00
Conference pass

Presentation: Enhancing Productivity with AI: Leveraging ChatGPT for EDSR

AI & Automation
Uzodinma Ndibe, Director, Medical Safety Assessment Physician, Bristol Myers Squibb
Nov 511:00
Conference pass

Presentation: Navigating Complex Regulatory Frameworks Across the Middle East

Global PV & Regulatory
Yasmine Fekry, Middle East Multi Country Safety Head , Global Pharmacovigilance, Sanofi
Nov 511:00
Conference pass

Presentation: Operations as a Science - Paving the way Forward for the Standardization of PV Tasks

Quality Assurance
Edward Mingle, Executive Director, Head PV Digital Operations, Takeda
Nov 511:00
Conference pass

Presentation: Assessment of the NHSE Dataset's Suitability for Contextualizing Safety Risks

Next Gen Tech & Data
Samad Jahendideh, Director, Patient Safety, Astrazeneca
Nov 511:00
Conference pass

Presentation: Challenges of “Thinking Global” and “Acting Local” in a Global Pharmacovigilance Setting

Patient Safety & Centricity
Gloria Bustos, Global Head Global Patient Safety, Vantive
Nov 511:00
Conference pass

Presentation: To be announced

Safety Risk Management
Reema Mehta, Vice President, Head of Risk Assessment and Management, PFIZER
Nov 511:00
Conference pass

Presentation: To be announced

Digital Transformation

To be announced.

Nov 511:20
Conference pass

Presentation: Automation in Pharmacovigilance – Friend or Fiend

AI & Automation

Automation is already reshaping pharmacovigilance — quietly, compliantly, and effectively. This session explores why automation, not AI, is the real innovation in safety-critical workflows. We’ll discuss regulatory expectations, current use cases, and how rule-based systems deliver reliable, auditable results. Whilst AI remains aspirational, automation is operational — and inspection-ready!

Objectives include:

  • Understand the key differences between automation and AI in pharmacovigilance.
  • Learn where automation is already successfully used in PV processes.
  • Explore regulatory expectations around validated systems and inspection readiness.
  • Assess risks of unvalidated AI versus the compliance benefits of automation.
  • Discover how hybrid models can balance automation with human oversight.

Sponsored by PharSafer.

Nov 511:20
Conference pass

Presentation: Sponsored by Arriello

Global PV & Regulatory

To be announced.

Nov 511:20
Conference pass

Presentation: Sponsored by COD Research

Safety Risk Management

Sponsored by COD Research.

Nov 511:20
Conference pass

Presentation: To be announced

Next Gen Tech & Data

Sponsored by Veeva.

Nov 511:20
Conference pass

Presentation: To be announced

Digital Transformation

Sponsored by IQVIA

Nov 511:20
Conference pass

Safety Updates for Cellular Therapies

Patient Safety & Centricity

Sponsored by APCER Life Sciences

David Chonzi, Medical Director, PV Safety Solutions
Vineet Kacker, Managing Director, apcer life sciences
Nov 511:40
Conference pass

Panel to be announced

Global PV & Regulatory

Reserved for sponsor.

Nov 511:40
Conference pass

Presentation: Smarter Pharmacovigilance: AI Support for PBRER Preparation

AI & Automation

This presentation describes a novel AI-driven system designed to support the authoring of Periodic Benefit-Risk Evaluation Reports (PBRERs), a critical component of pharmacovigilance. The system leverages generative AI, natural language processing, and machine learning to analyze safety data, generate draft content, and ensure alignment with regulatory expectations. Early prototypes have shown promising results in reducing manual workload and improving quality, consistency, and traceability in reporting. The presentation will share key technical insights, challenges encountered, and the potential impact on drug safety operations.

Katherine Quon, Global Periodic Reports Scientist, Amgen
Nov 511:40
Conference pass

Presentation: Affiliate Audits Reimagined: Tactics, Tools and Transformation

Quality Assurance

This session introduces an efficiency-focused approach to affiliate auditing. We will explore streamlined tactics, enabling tools, and transformation strategies that shift audits from routine assessments to high-impact, risk-based evaluations. The session will involve a discussion on how to enhance audit planning and enable data-driven decision-making - ensuring your audits deliver real value in today’s complex environment.

Kelly Kwon, Quality Assurance Affiliate Lead, Genentech
Nov 511:40
Conference pass

Presentation: To be announced

Next Gen Tech & Data

To be announced.

Nov 511:40
Conference pass

Presentation: To be announced

Digital Transformation

To be announced.

Nov 511:40
Conference pass

Presentation: Understanding Benefit-Risk Assessment in Oncology

Safety Risk Management
Celia Ezidiegwu, MD, Director, Oncology Medical Safety Officer, Johnson and Johnson Innovative Medicine
Nov 512:00
Conference pass

Presentation: Signal Detection in Early Phase Clinical Drug Trials

Safety Risk Management

Sponsored by Soterius.

Sumit Verma, President, Clinical Safety and Pharmacovigilance Operations, Soterius, Inc.
Nov 512:00
Conference pass

Presentation: From Clinical to Commercial: Safety Monitoring for Rare Gene Therapies

Patient Safety & Centricity
Nov 512:00
Conference pass

Presentation: To be announced

AI & Automation

Sponsored by Parexel.

Nov 512:00
Conference pass

Presentation: To be announced

Next Gen Tech & Data

Sponsored by Pinnaxis.

Nov 512:00
Conference pass

Presentation: To be announced

Digital Transformation

To be announced.

Nov 512:00
Conference pass

Presentation: To be announced

Quality Assurance

Reserved for sponsor.

Nov 512:20
Conference pass

Panel: Beyond Cost: Reclaiming Quality in Pharmacovigilance Outsourcing

Quality Assurance

As outsourcing in pharmacovigilance accelerates, how do we ensure patient safety isn’t compromised by cost-driven decisions? This panel explores the role of QA and QMS in the vendor selection process, making the case for pre-qualification audits and robust quality metrics before contracts are signed.

Join our thought leaders to debate how we can embed quality from the outset — and why PV QA voices must be central to outsourcing strategy.

The objectives of this panel discussion will:

  • Examine how QMS and KPIs can guide the selection and oversight of outsourced PV vendors.
  • Discuss the growing need for robust pre-qualification audits — not just post-selection oversight.
  • Debate whether cost is driving outsourcing decisions at the expense of quality.
  • Explore how QA teams can influence vendor selection with risk-based, patient safety–focused criteria.
  • Share strategies to embed quality metrics early in the decision-making process, not retrospectively.

Sponsored by PharSafer.

Nov 512:20
Conference pass

Panel: Delivering Transformative Results Not Hype, a Safety IT Perspective

Digital Transformation
Moderator: Andrew Mitchell, Founder / CEO, YEZA.ai
Sean Green, Director, Safety Database Strategy and Analytics, Apellis
Norm Fox, Director, Safety Database Strategy and Analytics, Nuvalent, Inc.
Nov 512:20
Conference pass

Panel: Patient Safety Considerations in High-Risk Therapeutic Innovation: CV and Rare Disease in Focus

Patient Safety & Centricity

Sponsored by Clinigen.

Ricardo Velazquez, Director of PV Medical Services, Clinigen
John Lee, MD PhD, President, LJ Biosciences LLC
David Chonzi, Medical Director, PV Safety Solutions
Nov 512:20
Conference pass

Panel: To be announced

Global PV & Regulatory
Moderator: Maria Anitan, Global Head of Pharmacovigilance and Drug Safety, Med Communications Inc
Nov 512:20
Conference pass

PR1SM: Patients Really are 1st in Signal Management A Novel Machine Learning Based Safety Alert Detection Application

AI & Automation
Nov 512:20
Conference pass
Nov 512:20
Conference pass

Presentation: To be announced

Next Gen Tech & Data

To be announced

Nov 512:40
Conference pass

Presentation: Operationalizing AI Software - A Business Context

AI & Automation

Sponsored by Ultragenic Research & Technologies LLC.

Amit Jain, Founder, Ultragenic Research & Technologies LLC
Nov 512:40
Conference pass

Presentation: The Voice of the Patient in Risk Management

Safety Risk Management
Carmit Strauss, Head of risk management, Organ toxicity and Benefit risk, Takeda
Nov 512:40
Conference pass

Presentation: To be announced

Next Gen Tech & Data

Sponsored by Oracle Health.

Nov 513:00
Conference pass

Networking, Poster, & Expo Break

Breaks

Networking, Poster, & Expo Break

Hall C
Nov 513:35
Conference pass

Track Chairperson's Opening Remarks

AI & Automation

Attendees will gain a deep understanding of how AI, machine learning, and automation are revolutionizing pharmacovigilance by streamlining case processing, enhancing signal detection, and driving operational efficiency. They will explore real-world applications, innovative tools, and forward-looking strategies to build trust in AI and future-proof safety operations across the drug development lifecycle.

Nov 513:35
Conference pass

Track Chairperson's Opening Remarks

Global PV & Regulatory

Attendees will gain insights into evolving global pharmacovigilance regulations, harmonization efforts, and compliance strategies across diverse markets. Through expert perspectives and case studies, they will explore how to navigate complex regulatory frameworks, align with international guidance, and implement best practices to ensure safety and compliance on a global scale.

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI
Nov 513:35
Conference pass

Track Chairperson's Opening Remarks

Safety Risk Management
Joan Daouza, Consultant, Consultant
Nov 513:35
Conference pass

Track Chairperson's Opening Remarks

Next Gen Tech & Data

Attendees will gain a forward-looking view of how emerging technologies and advanced data analytics are shaping the future of pharmacovigilance. They will explore innovations in real-world evidence, signal detection, and data integration to enhance decision-making, optimize safety monitoring, and support more proactive risk management.

Nov 513:35
Conference pass

Track Chairperson's Opening Remarks

Patient Safety & Centricity

To be announced.

Nov 513:35
Conference pass

Track Chairperson's Opening Remarks

Digital Transformation

To be announced.

Nov 513:35
Conference pass

Track Chairperson's Opening Remarks

Quality Assurance

To be announced.

Nov 513:40
Conference pass

Panel: Neuropharmacovigilance: Anticipating Cognitive Risk Signals in the Age of Digital Therapeutics and Psychedelic Drug Development

Digital Transformation
Matthew Johnson, Senior Researcher, Institute for Advanced Diagnostics and Therapeutics
Nov 513:40
Conference pass

Panel: To be announced

Patient Safety & Centricity

Sponsored by Syneos Health.

Nov 513:40
Conference pass

Panel: To be announced

Global PV & Regulatory

Panelists to be announced.

Sponsred by Orbit by Feith Systems.

Moderator: Kevin Fetterman, Executive Director, Orbit By Feith Systems
Nov 513:40
Conference pass

Presentation: Challenges in Pharmacovigilance Data Migration for Medium and Small Companies

Next Gen Tech & Data
Nov 513:40
Conference pass

Presentation: inspection/ audit realm or concerning deviations/CAPAs

Quality Assurance
Erika Barbarosie, Associate Director, Compliance, Pharmaceuticals
Nov 513:40
Conference pass

Presentation: To be announced

AI & Automation

Sponsored by ThermoFisher Scientific.

Nov 514:00
Conference pass

Presentation: The Role of Medical Doctors: Harnessing Medical Expertise in Risk Management

Safety Risk Management
Juan Daccach, Vice President, Global Product Safety, Merz Aesthetics
Nov 514:00
Conference pass

Presentation: To be announced

Next Gen Tech & Data

Reserved for sponsor.

Nov 514:00
Conference pass

Presentation: To be announced

Quality Assurance

Reserved for sponsor.

Nov 514:00
Conference pass

Presentation: TOTALVigilance in Action – A Case Study: Harnessing Agentic AI/ Automation/ Digital for Proactive PV Oversight, Operational Efficiency, and Global Process Harmonization

AI & Automation

Sponsored by Techsol Life Sciences.

Sriram Varma, Senior Vice President, PV Services, Techsol Life sciences
Satya Sagi, Founder & CEO, Techsol Life sciences
Nov 514:20
Conference pass

Fireside Chat: International Collaborations to Support Capacity Strengthening in PV

Global PV & Regulatory
Kendal Harrison, Head of Vigilance Development, Medicines and Healthcare products Regulatory Agency
Nov 514:20
Conference pass

Presentation: Patient Safety Blueprint: Strategies for Emerging Biotech Companies

Patient Safety & Centricity

As emerging biotech companies bring novel therapies to market at record pace, patient safety must remain a core pillar of success. Yet smaller organizations often face unique challenges, including limited resources, evolving infrastructure, and the need to navigate complex global regulatory landscapes. This session will outline practical, scalable strategies to build a robust patient safety framework from early development through commercialization. Topics will include embedding safety considerations into clinical development, leveraging technology and partnerships for efficient pharmacovigilance, aligning safety strategy with evolving regulations, and fostering a proactive safety culture across small teams. Attendees will gain a blueprint for prioritizing patient protection while maintaining innovation and agility, ensuring safety becomes a catalyst—not a barrier—to growth.

Nirjhar Chatterjee, Senior MD Pharmacovigilance, Crinetics
Nov 514:20
Conference pass

Presentation: AI Based Safety Algorithms in Cell and Gene Therapies

AI & Automation
Ram Vempati, PV Medical Consultant, CRISPR Therapeutics
Nov 514:20
Conference pass

Presentation: Global approaches to benefit-risk management following recent EMA, FDA, and CIOMS guidance

Safety Risk Management
Nov 514:20
Conference pass

Presentation: Quality Management Maturity: How to Strategically and Operationally Build and Scale a QMS Over Time as a Variable of the Product Development Lifecycle

Quality Assurance
Mandy Gervasio, VP, QA & Compliance, Comanche Biopharma
Nov 514:20
Conference pass

Presentation: Streamlining ICSR Replication with a new paradigm for accuracy and efficiency

Next Gen Tech & Data

Reserved for Transcelerate.

Nov 514:40
Conference pass

Panel: Navigating the ACNU Framework: Implications for Global Pharmacovigilance

Patient Safety & Centricity

As the ACNU framework continues to take shape, its implications across the pharmacovigilance (PV) ecosystem are becoming increasingly significant. Takeaways from this panel include:

  • Understanding the ACNU Framework
  • Benefits of ACNU to patients
  • Impact of ACNU on PV process
  • Technology and Innovation Requirements
  • Global Regulatory Considerations
Moderator: Namita Joshi, Regional Safety Head NA, Sanofi CHC
Karthik Babu P S, Global PV Operations Head, Opella
Nov 514:40
Conference pass

Panel: Newly Released - Benefit-Risk Balance for Medicinal Products, A CIOMS Working Group XII Report

Safety Risk Management

Panelists to be announced.

Nov 514:40
Conference pass

Presentation: Building trust in AI for drug safety: Lessons from developing a generative AI intake tool

AI & Automation

Sponsored by Syneos Health.

Jonathon Romero, AI and Machine Learning Specialist, Syneos Health
Asad Rashid, Vice President Safety and PV, Syneos Health LLC
Nov 514:40
Conference pass

Presentation: To be announced

Global PV & Regulatory

Reserved for sponsor

Nov 514:40
Conference pass

Presentation: To be announced

Next Gen Tech & Data

Reserved for sponsor.

Nov 514:40
Conference pass

Presentation: To be announced

Digital Transformation

Reserved for sponsor.

Nov 514:40
Conference pass

Presentation: To be announced

Quality Assurance

Reserved for sponsor.

Nov 515:00
Conference pass

Presentation: Country Specific PV: Navigating Legislative, Cultural, and Commercial Strategies in a GVP Environment

Global PV & Regulatory

When building or supporting country-specific PV, there are legislative, cultural, commercial, as well as strategic variables that need to be considered. Here we discuss the framework and tools we use, as well as the challenges and successes from a collective 2 decades of experience.

Tina Veizovic, Senior Director, GPS International and PV Partnerships, BeOne Medicines
Nov 515:00
Conference pass

Presentation: Long-term Follow-Up and Inspection Readiness for Gene Therapies

Quality Assurance
Nov 515:00
Conference pass

Presentation: The Renal Explorer: An Open-Source Interactive Graphical Tool to Detect Acute Renal Injury

Next Gen Tech & Data

The Renal Explorer is the latestopen-source tool from the Interactive Safety Graphics taskforce of the American Statistical Association's Biopharmaceutical Safety Working Group. This session will illustrate how instances of acute renal injury arising in clinical trials can be identified and evaluated by this interactive graphical tool.In addition, the accompanying clinical workflow will be introduced, which guides the safety scientist through a series of evaluations, explains how to interpret the results, all referenced back to the primary medical literature

Nov 515:00
Conference pass

Presentation: To be announced

Digital Transformation

To be announced.

Nov 515:00
Conference pass

Presentation:T o be announced

AI & Automation

To be announced.

Nov 515:20
Conference pass

Panel: Advances in safety signal detection using real-world data

Next Gen Tech & Data

For many years, real-world data — e.g., administrative claims and electronic health records — have played a critical role in medical product safety through traditional Post-Approval Safety Studies. With advances in real-world data availability, methods, and tools, real-world evidence is increasingly being used as part of routine pharmacovigilance activities in the signal management process. While less well established, there is growing interest in using secondary real-world data for signal detection to identify new safety observations. Covering multiple stakeholder perspectives, this panel will discuss the current state and future potential of real-world data in signal detection

Nov 515:20
Conference pass

Panel: From Overload to Access: Streamlining Global Pharmacovigilance in the Age of Information Surplus

Global PV & Regulatory

In today’s hyper-connected world, pharmacovigilance professionals are faced with an overwhelming abundance of data—ranging from peer-reviewed literature and clinical reports to social media signals and real-world evidence. While this information explosion holds immense potential for improving drug safety, it also presents significant challenges: fragmentation, duplication, and inequitable access, particularly in low- and middle-income countries (LMICs).

This session will explore how global stakeholders are working to streamline, standardize, and integrate diverse data sources to create more cohesive, actionable pharmacovigilance systems. Speakers will highlight innovative technologies, policy frameworks, and collaborative models that are helping to cut through the noise, prioritize meaningful signals, and democratize access to critical safety information.

Nov 515:20
Conference pass

Panel: Navigating Patient Safety: A Comparative Look Across Pharma, Devices, Cosmetics, and Combination Products

Patient Safety & Centricity

A panel on"Navigating Patient Safety: A Comparative Look Across Pharma, Devices, Cosmetics, and Combination Products"would explore the unique and overlapping safety challenges within each sector. Experts would discuss regulatory frameworks, risk management strategies, and post-market surveillance practices tailored to the specific nature of each product type. The conversation would highlight how innovation, globalization, and evolving consumer expectations are reshaping safety protocols. Ultimately, the session would aim to foster a more integrated approach to patient safety across the life sciences spectrum.

Moderator: Juan Daccach, Vice President, Global Product Safety, Merz Aesthetics
Omar Aimer, Executive Member of ISoP and NASoP President, International Society of Pharmacovigilance (ISoP)
Samina Qureshi, International Medical Officer, MedDRA MSSO
Ben Kitchens, Associate Director, Medical Devices, Diagnostics Lead, Otsuka Pharmaceutical Companies (U.S.)
Tasia-Leigh Deleon, Manager of Cosmetovigilance, CHANEL
Nov 515:20
Conference pass

Panel: Navigating the Future of PV Operations: Key Challenges and Emerging Trends

Quality Assurance
Juan Camilo Gonzalez, Head Pharmacovigilance Operations, Moderna
Karthik Muthusamy, Senior Director, Head Data Acquisition and Interfaces, Bristol Myers Squibb
Nov 515:20
Conference pass

Presentation: From Automation to Intelligence: The Pharmacovigilance Workforce of the Future

AI & Automation

Sponsored by Indegene.

Nikesh Shah, Vice President and Global Head, Drug Safety and Pharmacovigilance, Indegene
Siva Kumar Buddha, Director, Pharmacovigilance, Head of Signals and Risk Management, Indegene Inc.
Nov 515:20
Conference pass

Presentation: To be announced

Digital Transformation

To be announced.

Nov 515:40
Conference pass

Fireside chat: To be announced

Digital Transformation
Oleg Zvenigorodsky, Director, Medical Safety / Innovation Lead, Jazz Pharmaceuticals
Janaina Brothers, Senior Manager, Medical Safety, Jazz Pharmaceuticals
Nov 515:40
Conference pass

Presentation: To be announced

AI & Automation

To be announced.

Nov 516:00
Conference pass

Short beak before Keynotes

Breaks

Please join us in Hall C for our afternoon keynotes.

Nov 516:10
Conference pass

Keynote Fireside Chat: Navigating the responsible use of AI for Drug Safety

Keynotes

Other speakers to be announced.

Keynote Stage - Hall C
Nov 516:30
Conference pass

Keynote: To be announced

Keynotes

To be announced.

Keynote Stage - Hall C
Nov 516:50
Conference pass

Keynote Panel: Global synergy in pharmacovigilance: Bridging Borders for safer medicines

Keynotes

Other panelists to be announced.

Keynote Stage - Hall C
Nov 517:30
Conference pass

Happy Hour!

Breaks

Join us on the expo floor in Hall C for happy hour!

Create your personal agenda –check the favourite icon

Nov 68:00
Conference pass

Registration & Expo Hall Opens

Breaks

Registration & Expo Hall Opens

Nov 68:30
Conference pass

Keynote Chair Person's Opening Remarks

Keynotes

To be announced.

Keynote Stage - Hall C
Nov 68:35
Conference pass

Keynote: To be announced

Keynotes

Sponsored by Parexel.

Keynote Stage - Hall C
Nov 68:55
Conference pass

Keynote Panel: Regulatory Agency Innovation and Future PV Roadmaps. Where are we going?

Keynotes
Moderator: Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI
Rania Mouchantaf, Executive Director, Health Canada
Keynote Stage - Hall C
Nov 69:35
Conference pass

Keynote: To be announced

Keynotes

Sponsored by ArisGlobal.

Keynote Stage - Hall C
Nov 610:35
Conference pass

Networking, Poster, and Expo Hall Break

Breaks

Networking, Poster, and Expo Hall Break

Nov 611:10
Conference pass

Track Chairperson's Opening Remarks

AI & Automation

Attendees will gain a deep understanding of how AI, machine learning, and automation are revolutionizing pharmacovigilance by streamlining case processing, enhancing signal detection, and driving operational efficiency. They will explore real-world applications, innovative tools, and forward-looking strategies to build trust in AI and future-proof safety operations across the drug development lifecycle.

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI
Nov 611:10
Conference pass

Track Chairperson's Opening Remarks

Regulatory & Compliance

To be announced.

Nov 611:10
Conference pass

Track Chairperson's Opening Remarks

Safety Risk Management

Attendees will gain practical strategies for identifying, assessing, and mitigating safety risks throughout the product lifecycle. They will explore evolving approaches to benefit-risk management, REMS, and post-market surveillance, with insights into regulatory expectations and innovative tools to enhance patient safety and product oversight.

Joan Daouza, Consultant, Consultant
Nov 611:10
Conference pass

Track Chairperson's Opening Remarks

Next Gen Tech & Data

To be announced.

Nov 611:10
Conference pass

Track Chairperson's Opening Remarks

Patient Safety & Centricity

To be announced

Nov 611:10
Conference pass

Track Chairperson's Opening Remarks

PV Outsourcing

To be announced.

Nov 611:10
Conference pass

Track Chairperson's Opening Remarks

Innovation Showcase

To be announced.

Nov 611:15
Conference pass

Company Presentations

Innovation Showcase

To be announced.

Nov 611:15
Conference pass

Presentation: Fit-For-Purpose Real-World Data for Enhanced Patient Safety: Insights from Rapid Signal Assessment to ICH M14 Implementation

Next Gen Tech & Data
William Blumentals, Head of Pharmacoepidemiology, Specialty Care, Sanofi
Nov 611:15
Conference pass

Presentation: How to Plan for Early Phase Safety Strategies

Safety Risk Management
Abimbola Cole, Scientific Director, GSK
Nov 611:15
Conference pass

Presentation: Incorporating AI generated cases into databases: Supported by Human Quality Control

AI & Automation
Reinhold Schilling, Head of Global Pharmacovigilance, EU QPPV, Wörwag Pharma
Nov 611:15
Conference pass

Presentation: Regulatory & Compliance of EMA PASS Procedures

Regulatory & Compliance
Shefali Jobanputra, CPASS Compliance, Process and Training Lead, Takeda
Nov 611:15
Conference pass

Presentation: To be announced

PV Outsourcing
Milind Sardesai, Senior Director, Safety Surveillance, Global Patient Safety, Novo Nordisk
Nov 611:15
Conference pass

Presentation: Updates on SAR, AE intake, and other use cases

Patient Safety & Centricity
Anjali Shah, Executive Director, Business Capabilities and Innovation, Worldwide Patient Safety, bristol-myers squibb
Nov 611:35
Conference pass

Presentation: Challenges and Bias in PV Literature Review

Safety Risk Management

Sponsored by UBC.

Shivani Vithal-Patel, Senior Safety Scientist, UBC
Nov 611:35
Conference pass

Presentation: Future-proofing pharmacovigilance: Augmenting human expertise with advanced AI/ML technology

Regulatory & Compliance

In this session, you will explore the compelling benefits for pharmaceutical companies in combining human expertise with advanced technology to optimize pharmacovigilance operations. Learn how integrating human insights with cutting-edge tools, including AI and machine learning, pharma companies can achieve greater efficiency, accuracy, and compliance in their safety monitoring processes. Explore real-world examples and industry research to demonstrate the practical applications and benefits of these integrated solutions in enhancing pharmacovigilance operations.

Sponsoredd by IQVIA.

Archana Hegde, Senior Director, PV Systems & Innovations, Lifecycle Safety, IQVIA
Nov 611:35
Conference pass

Presentation: Generative to Agentic AI: Multiplying PV Writing Impact

AI & Automation

Sponsored by Quartica.

Ikram Baig, CEO, Quartica
Nov 611:35
Conference pass

Presentation: To be announced

Patient Safety & Centricity

To be announced.

Nov 611:35
Conference pass

Presentation: To be announced

PV Outsourcing

Sponsored by BioPoint.

Nov 611:35
Conference pass

Presentation: To be announced

Next Gen Tech & Data

Sponsored by Alwis Solutions.

Nov 611:55
Conference pass

Learning group: How can we Ensure Diversity and Inclusion in Clinical Trials?

Patient Safety & Centricity
Philisha Mack, Director of Drug Safety, Azurity Pharmaceuticals
Nov 611:55
Conference pass

Presentation: Quality and Content of Clinical Trial Safety Data in Public Information Sources

Next Gen Tech & Data
Barbara Hendrickson, Clinical Associate, University of Chicago
Nov 611:55
Conference pass

Presentation: Strategies that Support Risk Minimization Measures from Beginning to End

Safety Risk Management
Sharon Reid, Director Risk Management Product Lead, Pfizer
Nov 611:55
Conference pass

Presentation: To be announced

AI & Automation

To be announced.

Nov 611:55
Conference pass

Presentation: To be announced

Regulatory & Compliance
Jeremy Jokinen, Vice President, Safety Evidence and Sciences, Bristol Myers Squibb
Nov 611:55
Conference pass

Presentation: To be announced

PV Outsourcing

To be announced.

Nov 612:15
Conference pass

Presentation: Selecting or Re-evaluating your Drug Safety Service Provider

PV Outsourcing

Sponsored by Soterius.

Howard Abroms, Vice President, Global Business Development, Soterius, Inc.
Nov 612:15
Conference pass

Presentation: To be announced

AI & Automation

Sponsored by ClinChoice.

Nov 612:15
Conference pass

Presentation: To be announced

Regulatory & Compliance

Reserved for sponsor.

Nov 612:15
Conference pass

Presentation: To be announced

Safety Risk Management

Reserved for sponsor.

Nov 612:15
Conference pass

Presentation: To be announced

Next Gen Tech & Data

Reserved for sponsor.

Nov 612:35
Conference pass

Panel: Reference Safety Information in Practice: From Global Standards to Local Execution

Regulatory & Compliance

As the regulatory landscape evolves, the implementation of Reference Safety Information (RSI) has become a cornerstone of effective pharmacovigilance. This panel will explore how companies navigate the complexities of RSI implementation, from aligning with global standards to addressing region-specific regulatory expectations and operational challenges. Experts will discuss strategies for maintaining consistency across regions, integrating updates into safety systems, and ensuring clear communication with investigators and regulators. Attendees will gain practical insights on best practices, common pitfalls, and the future of RSI management in an increasingly connected global environment.

Moderator: Rupesh Patel, Director, Global Patient Safety Quality Management, Exelixis
Nov 612:35
Conference pass

Panel: Smart Safety: The Future of Risk Management Through Technology

Safety Risk Management
Nov 612:35
Conference pass

Panel: Technology: Unlocking the Better ways in PV for Safer Drugs

Next Gen Tech & Data
Moderator: Heather Leigh Flannery, Chief Executive Officer & Co-Founder, AI MINDSystems Foundation
Beena Wood, Global Head of Innovation and Technology, CSL Behring
Matthew Dormarunno, Head of Global Safety Sciences,, CSL Behring
E. Alton Sartor, Medical Director, Safety Digital and Devices, Astrazeneca
Tarak Thakker, Director, Safety Systems and Reporting, BeOne Medicines
Nov 612:35
Conference pass

Panel: The Outsourcing Partnership Playbook: Bridging Expectations, Boosting Productivity, and Achieving Mutual Success

PV Outsourcing

Outsourcing safety activities offers several strategic and operational benefits to sponsors. It spans from Global footprint to cost efficiency encompassing access to specialized knowledge, and scalability, among others. However, there are several challenges that need to be taken into consideration. For example, oversight, differences in time zones, quality issues and non-compliance, vendor dependency, costs, and others. Recognizing those factors is the recipe for a successful outsourcing partnership which will be explored in this panel discussion.

Sponsored by ThermoFisher Scientific.

Moderator: Gerson Peltz, Senior Vice President of Patient Safety & Pharmacovigilance, Arcus Biosciences Inc
April Pierce, Vice President Pharmacovigilance, Thermo Fisher Scientific
Nov 612:35
Conference pass

Presentation: Enhancing Patient Safety: Integrating Active and Passive Monitoring in Modern Pharmacovigilance

Patient Safety & Centricity
Nov 612:35
Conference pass

Presentation: To be announced

Innovation Showcase

Reserved for sponsor.

Nov 612:35
Conference pass

Reserved for Propharma

AI & Automation

Sponsored by Propharma.

Nov 612:55
Conference pass

Presentation: To be announced

Patient Safety & Centricity

Reserved for sponsor.

Nov 612:55
Conference pass

Presentation: To be announced

Innovation Showcase

Reserved for sponsor.

Nov 613:15
Conference pass

Fireside chat: How can PV participate in precision medicine?

Next Gen Tech & Data
Dennis Van Liew, Board Member Emeritus, Personalized Medicine Coalition
Nov 613:15
Conference pass

Networking, Poster, & Expo Break

Breaks

Networking, Poster, & Expo Break in Expo Hall C

Nov 613:50
Conference pass

Track Chairperson's Opening Remarks

Patient Safety & Centricity

To be announced.

Nov 613:50
Conference pass

Track Chairperson's Opening Remarks

AI & Automation

Attendees will gain a deep understanding of how AI, machine learning, and automation are revolutionizing pharmacovigilance by streamlining case processing, enhancing signal detection, and driving operational efficiency. They will explore real-world applications, innovative tools, and forward-looking strategies to build trust in AI and future-proof safety operations across the drug development lifecycle.

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI
Nov 613:50
Conference pass

Track Chairperson's Opening Remarks

Regulatory & Compliance

To be announced.

Nov 613:50
Conference pass

Track Chairperson's Opening Remarks

Safety Risk Management

Attendees will gain practical strategies for identifying, assessing, and mitigating safety risks throughout the product lifecycle. They will explore evolving approaches to benefit-risk management, REMS, and post-market surveillance, with insights into regulatory expectations and innovative tools to enhance patient safety and product oversight.

Joan Daouza, Consultant, Consultant
Nov 613:50
Conference pass

Track Chairperson's Opening Remarks

Next Gen Tech & Data

To be announced.

Nov 613:50
Conference pass

Track Chairperson's Opening Remarks

Device & Vaccine Safety

To be announced.

Nov 613:50
Conference pass

Track Chairperson's Opening Remarks

Innovation Showcase

To be announced.

Nov 613:55
Conference pass

Panel: Next-generation of PV Experts

Innovation Showcase
Moderator: Edward Mingle, Executive Director, Head PV Digital Operations, Takeda
Nov 613:55
Conference pass

Panel: Rebuilding Safety Around the Patient: Moving Medical Safety Beyond the Silo and Back to the Bedside

Patient Safety & Centricity

In an era of increasing complexity in drug development and real-world use, patient safety must be re-centered as a multidisciplinary, patient-facing function - not just a regulatory requirement. This panel,Rebuilding Safety Around the Patient: Moving Medical Safety Beyond the Silo and Back to the Bedside, explores how safety science can evolve beyond traditional silos to actively engage with patients, clinicians, and data at the point of care. Panelists will share practical strategies for bridging the gap between pharmacovigilance and patient experience through cross-functional collaboration, patient-reported outcomes, and ethical transparency. Join us for a thought-provoking discussion on reimagining medical safety as a bedside ally rather than a back-office function.

Vishnuvardhan Reddy Peddagali, Vice President, Global Head of Pharmacovigilance and Risk Management, Sumitomo Pharma America Inc.
Nov 613:55
Conference pass

Presentation: DSUR/PSUR from 3 months to 3 seconds AI learnings and deployment

Regulatory & Compliance
Nov 613:55
Conference pass

Presentation: Safety of SPIKEVAX in Pregnant Women and Their Offspring

Device & Vaccine Safety
Veronica Urdaneta, Global Clinical Safety Lead, COVID-19 Franchise - Global Safety Physician, Moderna
Nov 613:55
Conference pass

Presentation: To be announced

AI & Automation

To be announced.

Nov 613:55
Conference pass

Presentation: To be announced

Safety Risk Management
Chris Bone, Director, Safety and Benefit Risk, Biogen
Nov 614:15
Conference pass

Presentation: To be announced

Next Gen Tech & Data

Reserved for sponsor.

Nov 614:15
Conference pass

Presentation: To be announced

Device & Vaccine Safety

Reserved for sponsor.

Nov 614:15
Conference pass

Presentation: To be announced

AI & Automation

Reserved for sponsor.

Nov 614:15
Conference pass

Presentation: To be announced

Regulatory & Compliance

Reserved for sponsor.

Nov 614:15
Conference pass

Presentation: To be announced

Safety Risk Management

Reserved for sponsor.

Nov 614:35
Conference pass

Presentation: Nonclinical Assessment of the Target Organ Safety in Drug Discovery and its Translational Value for Human Subjects

Next Gen Tech & Data
Nov 614:35
Conference pass

Presentation: To be announced

Regulatory & Compliance

To be announced.

Nov 614:35
Conference pass

Presentation: To be announced

AI & Automation

To be announced.

Nov 614:35
Conference pass

Presentation: To be announced

Innovation Showcase

To be announced.

Nov 614:35
Conference pass

Presentation: To be announced

Safety Risk Management

To be announced.

Nov 614:35
Conference pass

Presentation: To be announced

Patient Safety & Centricity

To be announced.

Nov 614:35
Conference pass

Presentation: To be announced

Device & Vaccine Safety

To be announced.

last published: 02/Jul/25 19:45 GMT

Get Involved At Drug Safety Congress Americas

 

CONNECT WITH US

 

To Sponsor

Semen Sen
semen.sen@terrapinn.com
t/ + 646-619-1793

 

To Speak

Kaylee Nguyen
kaylee.nguyen@terrapinn.com

 

Marketing & Press

Emily Ngai
emily.ngai@terrapinn.com